Literature DB >> 19723540

Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells.

D J Mahad1, I Ziabreva, G Campbell, F Laulund, J L Murphy, A K Reeve, L Greaves, K J Smith, D M Turnbull.   

Abstract

Cytochrome c oxidase or mitochondrial respiratory chain complex IV is where over 90% of oxygen is consumed. The relationship between complex IV activity and mitochondrial proteins, which provides a guide to understanding the mechanisms in primary mitochondrial disorders, has been determined by histochemistry (activity) and immunohistochemistry in serial sections. In the central nervous system (CNS), mitochondrial activity and immunoreactivity have been determined in populations of cells in serial sections as capturing cells in more than one section is difficult. In this report we describe a method to determine complex IV activity in relation to mitochondrial proteins at a single cell level in the CNS. We performed complex IV histochemistry and immunohistochemistry consecutively in snap frozen sections. Although the product of complex IV histochemistry reduces the sensitivity of standard immunohistochemistry (secondary antibody and ABC method) the biotin-free Menapath polymer detection system (A. Menarini Diagnostics, Wokingham, UK) enables mitochondrial proteins to be detected following complex IV histochemistry. The co-occurring chromogens may then be separately visualised and analysed using multi-spectral imaging (Nuance system CRi, Woburn, MA). Our technique is applicable for exploring mitochondrial defects within single cells in a variety of CNS disorders and animal models of those diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723540     DOI: 10.1016/j.jneumeth.2009.08.020

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  13 in total

1.  Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Neal Flomenberg; Ruth C Birbe; Agnieszka K Witkiewicz; Anthony Howell; Stephanos Pavlides; Aristotelis Tsirigos; Adam Ertel; Richard G Pestell; Paolo Broda; Carlo Minetti; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

2.  Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease.

Authors:  Zuzana Sisková; Don Joseph Mahad; Carianne Pudney; Graham Campbell; Mark Cadogan; Ayodeji Asuni; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

3.  Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue.

Authors:  Ashwin Sachdeva; Claire A Hart; Christopher D Carey; Amy E Vincent; Laura C Greaves; Rakesh Heer; Pedro Oliveira; Michael D Brown; Noel W Clarke; Doug M Turnbull
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

4.  Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.

Authors:  Graham R Campbell; Yevgenya Kraytsberg; Kim J Krishnan; Nobuhiko Ohno; Iryna Ziabreva; Amy Reeve; Bruce D Trapp; Jia Newcombe; Richard Reynolds; Hans Lassmann; Konstantin Khrapko; Doug M Turnbull; Don J Mahad
Journal:  Acta Neuropathol       Date:  2012-06-12       Impact factor: 17.088

5.  Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.

Authors:  Joseph M Curry; Madalina Tuluc; Diana Whitaker-Menezes; Julie A Ames; Archana Anantharaman; Aileen Butera; Benjamin Leiby; David M Cognetti; Federica Sotgia; Michael P Lisanti; Ubaldo E Martinez-Outschoorn
Journal:  Cell Cycle       Date:  2013-04-10       Impact factor: 4.534

6.  A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis.

Authors:  Mariana C Rocha; John P Grady; Anne Grünewald; Amy Vincent; Philip F Dobson; Robert W Taylor; Doug M Turnbull; Karolina A Rygiel
Journal:  Sci Rep       Date:  2015-10-15       Impact factor: 4.379

7.  The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons.

Authors:  Amy Reeve; Martin Meagher; Nichola Lax; Eve Simcox; Philippa Hepplewhite; Evelyn Jaros; Doug Turnbull
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

8.  Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study.

Authors:  Nichola Zoe Lax; Philippa Denis Hepplewhite; Amy Katherine Reeve; Victoria Nesbitt; Robert McFarland; Evelyn Jaros; Robert William Taylor; Douglass Matthew Turnbull
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

9.  Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.

Authors:  Jenny L Wilkerson; Katherine R Gentry; Ellen C Dengler; James A Wallace; Audra A Kerwin; Megan N Kuhn; Alexander M Zvonok; Ganesh A Thakur; Alexandros Makriyannis; Erin D Milligan
Journal:  Brain Behav       Date:  2012-03       Impact factor: 2.708

10.  Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue.

Authors:  Anne Grünewald; Nichola Z Lax; Mariana C Rocha; Amy K Reeve; Philippa D Hepplewhite; Karolina A Rygiel; Robert W Taylor; Doug M Turnbull
Journal:  J Neurosci Methods       Date:  2014-05-29       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.